[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100625808":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":33,"centralContacts":38,"locations":44,"responsibleParty":57,"collaborators":42,"id":60,"slug":61,"hasResults":62,"nctId":63,"briefTitle":64,"officialTitle":65,"acronym":42,"eligibilityCriteria":66,"healthyVolunteers":62,"sex":67,"minAge":68,"maxAge":69,"enrollmentInfo":70,"targetDuration":42,"studyType":73,"phases":74,"briefSummary":76,"conditions":77,"keywords":79,"overallStatus":47,"whyStopped":42,"lastUpdateSubmitDate":85,"lastUpdatePostDateStruct":86,"startDateStruct":89,"completionDateStruct":91,"leadSponsor":93,"locationsCount":94},{"fullName":5,"class":6},"Kasr El Aini Hospital","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Dexmedetomidine-Midazolam","ACTIVE_COMPARATOR","Children will receive Dexmedetomidine + Midazolam",[13],"Drug: Dexmedetomidine and Midazolam",{"label":15,"type":10,"description":16,"interventionNames":17},"ketamine-Midazolam","Children will receive ketamine + Midazolam",[18],"Drug: Ketamine and Midazolam",[20,27],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"DRUG","Dexmedetomidine and Midazolam","Children will receive Dexamedetomedine and Midazolam",[9],[26],"Precedex and Dormicum",{"type":21,"name":28,"description":29,"armGroupLabels":30,"otherNames":31},"Ketamine and Midazolam","Children will receive Ketamine and Midazolam",[15],[32],"katalar and Dormicum",[34],{"name":35,"affiliation":36,"role":37},"Ahmed Elhaddad, Ass.prof.","Faculty of medicins,Cairo university","PRINCIPAL_INVESTIGATOR",[39],{"name":35,"role":40,"phone":41,"phoneExt":42,"email":43},"CONTACT","01224042847",null,"drblacksmith@gmail.com",[45],{"facility":46,"status":47,"city":48,"state":42,"zip":42,"country":49,"countryCode":50,"cosmosGeoPoint":51,"geoPoint":56,"contacts":42},"Kasralainy Hospital","RECRUITING","Cairo","Egypt","EG",{"type":52,"coordinates":53},"Point",[54,55],31.24967,30.06263,{"lat":55,"lon":54},{"type":37,"investigatorFullName":58,"investigatorTitle":59,"investigatorAffiliation":5,"oldNameTitle":42,"oldOrganization":42},"Ahmed Mohamed Mohamed Elhaddad","Assisstent Professor","100625808","phase-4-dexmedetomidine-midazolam-vs-ketamine-midazolam-on-emergence-delirium-100625808",false,"NCT07427446","Dexmedetomidine-Midazolam vs. Ketamine-Midazolam on Emergence Delirium","Prophylactic Effect of Dexmedetomidine-midazolam Versus Ketamine-midazolam on Emergence Delirium After Sevoflurane Anesthesia in Pediatric Cardiac Catheterization: A Randomized Controlled Study.","Inclusion Criteria:\n\n* Scheduled for elective cardiac catheterization under general anesthesia.\n\nExclusion Criteria:\n\n* neurological disorder, psychiatric disease, or current psychoactive medication.\n* allergy.\n* significant systemic comorbidities.","ALL","2 Years","6 Years",{"count":71,"type":72},50,"ESTIMATED","INTERVENTIONAL",[75],"PHASE4","Fifty children undergoing heart catheterization without local anesthesia in the skin will be randomly divided into two groups.\n\nGroup DM (Dexmedetomidine + Midazolam) and Group KM (Ketamine + Midazolam)",[78],"Emergence Delirium",[80,81,82,83,84],"Emergence delirium","Dexmedetomidine","Ketamine","Midazolam","sevoflurane","2026-02-24",{"date":87,"type":88},"2026-02-27","ACTUAL",{"date":90,"type":88},"2026-02-01",{"date":92,"type":72},"2027-03",{"name":5,"class":6},1]